We previously reported that GSK3β inhibition sensitizes human GBM cell lines to TMZ through up-regulation of DNA methyltransferase 3A (DNMT3A) that methylates O-6-methylguanine methyltransferase (MGMT) promoter via c-Myc up-regulation14. This evidence concerns the gene DNMT3A and glioblastoma.